US to stop sup­ply­ing Lil­ly's mAb for Covid-19 this month as com­mer­cial mar­ket awaits

Fed­er­al of­fi­cials said yes­ter­day that ship­ments of Eli Lil­ly’s bebtelovimab — one of the fi­nal two re­main­ing mAb treat­ments for Covid-19 — would halt lat­er this month …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER